Cite
HARVARD Citation
Goel, S. et al. (2019). CDK4/6 inhibitors in breast cancer: a role in triple-negative disease?. Lancet oncology. 20 (11), pp. 1479-1481. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Goel, S. et al. (2019). CDK4/6 inhibitors in breast cancer: a role in triple-negative disease?. Lancet oncology. 20 (11), pp. 1479-1481. [Online].